Multicell Technologies News
News
0
Ticker
MCET
ISIN
US62544S2005
Multicell Technologies Eulerpool News
Multicell Technologies Stock News
Multicell Technologies is being monitored by journalists and investors worldwide. We gather the latest Multicell Technologies news here.
- March 4·CNBC
- February 24·CNBC
- January 13·CNBC
- January 11·CNBC
- January 10·CNBC
- January 6·CNBC
- December 26·CNBC
- December 21·CNBC
- December 2·Nasdaq
- December 2·Nasdaq
- December 2·Nasdaq
- December 2·Nasdaq
- December 2·Nasdaq
- December 2·Nasdaq
- November 30·Nasdaq
- November 30·Nasdaq
- November 30·Nasdaq
- November 29·Nasdaq
- November 28·Nasdaq
- November 28·Nasdaq
Multicell Technologies Stock Press Releases
Multicell Technologies regularly publishes news on the company's website that are relevant for investors.
Multicell Technologies News 2026
This page contains all current news, analysis and press releases for Multicell Technologies stock (MCET, ISIN: US62544S2005). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Multicell Technologies.
Multicell Technologies Stock
Multicell Technologies Multicell Technologies Inc is a US-American company specialized in the development and production of innovative products in the field of biomedical and biotechnological research. The company was founded in 1987 by a team of scientists and has held a leading position in the industry ever since. They develop technologies for the isolation and artificial reproduction of cell cultures, collaborate with leading scientists and research institutions to develop new methods and products for fighting diseases such as cancer and cardiovascular diseases, and offer a wide range of products for biomedical and biotechnological research, including cell culture systems, antibody products, and specialized analysis tools. They also work on the production of cell lines and cultures and develop active therapeutics, including a program for developing a new therapeutic for multiple sclerosis. Additionally, they have a diagnostics business and have developed a special platform for DNA sequencing. Overall, Multicell Technologies Inc is known for its close collaboration with the scientific community and its dedication to developing innovative products for the medical field.